RxDoctor Payments Data

Jennifer Simpson

Family · Lima, OHNPI 1700387537

Payments from drug & device makers

$558in general payments, 2019–2025

Across 19 payments — averaging $29.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rochester Medical Corporation$167
  • AstraZeneca$86
  • Pfizer$71
  • Novo Nordisk$50
  • Exact Sciences$40
  • Amgen$39
  • plus $103 from 5 others

What the payments were for

  • Food & beverage$558100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$558 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$44,336
Medicare patients
136
Services billed
1,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$79,055
MounjaroTirzepatide48$49,750
EliquisApixaban32$44,831
JardianceEmpagliflozin16$25,549
TrulicityDulaglutide15$21,329
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$21,143
FarxigaDapagliflozin Propanediol17$18,200
SymbicortBudesonide/Formoterol Fumarate19$7,087
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$2,858
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen112$2,204
Albuterol Sulfate HfaAlbuterol Sulfate72$1,954
SynthroidLevothyroxine Sodium44$1,927
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen86$1,901
Gabapentin90$1,722
Omeprazole110$1,694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$50$79,05559 claims
PfizerEliquis$71$44,83132 claims
AstraZenecaFarxiga, Symbicort$86$25,28836 claims
AbbVieSynthroid$22$1,92744 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →